Received Mar 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 9HM59 | IM / LA |
got sick again; This non-serious case was reported by a consumer via call center representative and described the occurrence of sickness in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number 9HM59, expiry date 30-SEP-2023) for prophylaxis. On 01-DEC-2022, the patient received the 1st dose of Shingrix (intramuscular, left deltoid) .5 ml. On an unknown date, an unknown time after receiving Shingrix, the patient experienced sickness (Verbatim: got sick again). The outcome of the sickness was unknown. It was unknown if the reporter considered the sickness to be related to Shingrix. It was unknown if the company considered the sickness to be related to Shingrix. Additional Information: GSK receipt date: 27-FEB-2025 The reporter was the patient she declined all demographics and her date of birth. The patient reported that she received the first dose of Shingrix and never got the second dose of Shingrix. The patient did take other chronic medications (Declined Providing Unknown Product Information), but did not remember if she took them that same day before she got the first dose of the Shingrix vaccine. The patient did had a rare health conditions, but it was unknown if these were pre-existing receiving the first dose of Shingrix (Declined Providing Medical History Information) and, the patient reported that she did not get her second dose of Shingrix per the recommended dosing schedule because her Physician wanted her to get over the acute phase of her rare health condition first, which lasted a long time. The patient reported that then she forgot to get the second dose of Shingrix once she was over the acute phase of her rare health condition, but then got sick again. No further information was provided. The patient states that she was sensitive to other medications, but not vaccines (no further information provided).